Cite
MLA Citation
Dingwei Ye et al.. “78 T-Cell, MHC i, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A48–A49. http://access.bl.uk/ark:/81055/vdc_100144718448.0x00000a